Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced a second indication approval from China’s...
CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that China’s National Medical Products Administration (NMPA)...
Ty Biotech (HKG: 1332) has announced a strategic cooperation agreement with Shenzhen University to commercialize...
Insilico Medicine (HKG: 3696), a leading artificial intelligence (AI) drug discovery platform, has announced a...
Luye Pharma Group Limited (HKG: 2186) has announced the initiation of a Phase II clinical...
GlaxoSmithKline plc (GSK, NYSE: GSK) has completed its acquisition of 35Pharma Inc., a Canadian biopharmaceutical...
Shionogi & Co., Ltd. (TYO: 4507) has announced the completion of its first corporate venture...
Zai Lab (NASDAQ: ZLAB, HKG: 9688) and Boehringer Ingelheim (BI) have announced a strategic clinical...
3SBio Inc. (HKG: 1530) and Hangzhou Tigermed Consulting Co., Ltd. (SHE: 300347, HKG: 3347), China’s...
Daiichi Sankyo Co., Ltd. (TYO: 4568) has announced an agreement to transfer all shares of...
Bayer AG (ETR: BAYN) announced that China’s National Medical Products Administration (NMPA) has granted marketing...
Johnson & Johnson (J&J, NYSE: JNJ) has entered into an exclusive marketing promotion agreement with...
Novo Nordisk (NYSE: NVO) announced on April 14, 2026, a strategic partnership with OpenAI that...
Shanghai Fosun Pharmaceutical Group Co., Ltd. (SHA: 600196, HKG: 2196) announced it has received regulatory...
The State Council released the “Opinions on Improving the Drug Pricing Mechanism” this week, introducing...
Gan & Lee Pharmaceuticals (SHA: 603087) announced the first subject dosing in a Phase III...
AC Immune SA (NASDAQ: ACIU) and Eli Lilly and Company (NYSE: LLY) announced a revised...
Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership...
Er-Kim announced on April 14, 2026, that it has signed an exclusive commercialization agreement with...
UCB (EBR: UCB) announced that the European Commission (EC) has granted marketing approval under exceptional...